Viewing StudyNCT05722795



Ignite Creation Date: 2024-05-06 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05722795
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-02-10
First Post: 2022-04-11

Brief Title: Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer I-CONIC
Sponsor: Vastra Gotaland Region
Organization: Vastra Gotaland Region

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-02-06
Start Date Type: ESTIMATED
Primary Completion Date: 2024-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2022-04-11
First Submit QC Date: February 1 2023
Study First Post Date: 2023-02-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-01
Last Update Post Date: 2023-02-10
Last Update Post Date Type: ACTUAL